Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study
在基于价值的常规护理中使用Tildrakizumab的患者自述健康状况:IV期阳性研究的52周中期数据
期刊:
影响因子:
doi:10.2147/PTT.S526748
Mrowietz, Ulrich; Sommer, Rachel; Gerdes, Sascha; Reguiai, Ziad; Weger, Wolfgang; Daudén, Esteban; Maul, Julia-Tatjana; Ghislain, Pierre-Dominique; Laws, Philip M; Naldi, Luigi; De Jong, Elke; Mburu, Sicily; Koscielny, Volker; Massana, Eric; Domenech, Arnau; Gaarn du Jardin, Kristian; Kasujee, Ismail; Augustin, Matthias